Form 4: Roivant Sciences Director James C. Momtazee Reports Changes in Beneficial Ownership

James C. Momtazee, a director of Roivant Sciences Ltd., reports acquisition and disposal of common shares to satisfy tax obligations.

Summary

• On April 17, 2025, James C. Momtazee, a director of Roivant Sciences Ltd., reported changes in beneficial ownership of the company's common shares.
• Momtazee acquired 1,379 common shares as an award under the Issuer's Non-Employee Director Compensation Plan, at a price of $0 per share.
• He also disposed of 276 common shares at $10.15 per share to cover tax withholding obligations related to the vesting of previously granted shares.
• Following these transactions, Momtazee beneficially owns 95,710 common shares of Roivant Sciences Ltd.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing changes in share ownership due to compensation and tax obligations, indicating a neutral sentiment.

Positives

• The acquisition of shares reflects ongoing participation in the company's compensation plan.

Industry Context

This filing is a routine disclosure related to insider transactions and compensation plans, common in publicly traded companies.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, primarily reflecting internal compensation adjustments.

Key Dates

Keywords

Roivant Sciences, Director, Beneficial Ownership, Common Shares, Form 4, SEC, Momtazee, Tax Withholding